New MAP Biosystems JV Created to Reposition Existing Drugs | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Berg Biosystems and GNS Healthcare today announced a joint venture to "unlock the key molecular drivers of complex diseases and drug efficacy and safety."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.